On March 18, 2009, StopAfib.org represented the atrial fibrillation patient community at the FDA Cardiovascular and Renal Drugs Advisory Committee hearings on a replacement for amiodarone. We greatly appreciate you sharing your many stories so that we could share your experiences with the FDA. I had promised to share my comments with the afib patient …
For those atrial fibrillation patients who are on amiodarone, or for those avoiding it, there is good news. Multaq® (dronedarone), a replacement for amiodarone, received priority review status from the US FDA. While amiodarone is among the most effective atrial fibrillation medications, it has major toxicity issues that dronedarone doesn't display. Read more...